Italfarmaco S.p.A.
Records under this name other than the patents Italfarmaco S.p.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,273,730 | Use of estriol in low doses Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,835,414 | Treatment of vaginal atrophy in women with cardiovascular pathology risk Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,114,143 | Treatment of vaginal atrophy in women with tumor pathology risk Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,227,515 | Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments Term ended Term ended Apr 23, 2026 · USPTO record | Term ended | Term ended Apr 23, 2026 | USPTO record |
| US 8,637,702 | Derivatives of N-hydroxybenzamide for treating HIV infections Lapsed on the fee record Ended Jan 28, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 28, 2026 | USPTO record |
| US 7,635,788 | Alpha-amino acid derivatives with antiinflammatory activity Term ended Term ended Dec 2, 2025 · USPTO record | Term ended | Term ended Dec 2, 2025 | USPTO record |
| US 7,329,689 | Monohydrate Hydrochloride of the 4-Hydroxycarbamoyl-PHENYL)-CARBAMIC Acid (6-Diethylaminomethyl-NAPHTALEN-2-YL) Ester Term ended Term ended Jan 15, 2024 · High confidence | Term ended | Term ended Jan 15, 2024 | High confidence |
| US 7,235,689 | Hydroxamic acid derivatives having anti-inflammatory action Term ended Term ended Jan 7, 2024 · USPTO record | Term ended | Term ended Jan 7, 2024 | USPTO record |
| US 7,157,099 | Sustained release pharmaceutical compositions for the parenteral administration of hydrophilic compounds Term ended Term ended Feb 1, 2023 · USPTO record | Term ended | Term ended Feb 1, 2023 | USPTO record |
| US 7,427,620 | Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes Lapsed on the fee record Ended Sep 23, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 23, 2020 | USPTO record |